Charcot-Marie-Tooth disease (CMT) is the most frequent of the motor and sensory peripheral neuropathies.' CMT type 1, the most common form of the disease, is characterised clinically by distal muscle atrophy, a decrease in nerve conduction velocity, and demyelination of nerve fibres.' Inherited as an autosomal dominant trait, the subtype CMT1A has recently been associated with the partial duplication of the subband 17pll.2, spanning 1.5 Mb.2' Although smaller duplications have been recently described,' the great majority of the patients showed a duplicated segment of the same size. These data allowed Pentao et al7 to propose a mechanism of rearrangement involving two repetitive elements located 1-5 Mb apart in unaffected subjects.
Recently, Chance et al8 described patients with a distinct peripheral neuropathy, named hereditary neuropathy with liability to pressure palsies (HNPP), and associated with deletions of the region found to be duplicated in 
was fractionated in 1 % agarose gels in 0 5 x TBE at 200 V, with pulse time from 45 to 120 seconds at 12°C for 24 hours. The DNA was transferred to Pall Biodyne B membrane and hybridised to end probes, in order to localise the NotI sites in the YACs.
Results and discussion We analysed YACs described in a previous paper9 to determine if these clones contained microsatellites which had been localised, by Genethon, in the pericentromeric region of the short arm ofchromosome 17.1011 Using primers designed by Genethon ( ,r. Localisation offive microsateUlites on a NotI genomic map obtained from YAC restriction analysis (see Materials and methods). A genomic map of this region has recently been constructed by Pentao et al.7 Ofparticular interest is the localisation of the NotI sites, which have been positioned with respect to the breakpoints associated with the CMT1A duplication. We mapped the NotI sites in the different YACs (chimeric YACs, like 804F11, or giving inconsistent mapping data, like 856A6 and 955E12, were not taken into account in this work), allowing us to propose the map presented in the figure. From the presence of the microsatellite loci in the various YACs, we deduced intervals where these clones should be localised on the genomic DNA. We concluded that the three microsatellite loci D17S793, D17S839, and D17S955 are located in the CMT1A duplicated region of CMT1A, as they are all present in at least one of the three YACs, 124C3, 884G12, and 804F11, entirely included in this region. D17S921 is present in YAC 887H5 and not in 884G12 and thus may be located at the distal end of the CMT1A duplicated region. The present YAC mapping does not give sufficient resolution to determine this and the issue may be resolved by genotyping of affected subjects. Interestingly, three of the newly isolated markers are located in the distal half of the CMT1A region, allowing its duplicated status to be determined (as partial duplications, involving only the proximal part of the region, as has been recently described).
These microsatellites are very informative (table 1) , and this enhancement in the number of polymorphic markers in the region will increase the chances that parent and child are informative for one marker. These molecular resources will thus constitute a very powerful tool in the diagnosis of CMT1A. Testing this on a large number of CMT1A patients is in progress. 
